Voluntary Unpaid Plasma Donation
,
Abstract
No Abstracts No Abstracts No Abstracts
1. Chegini A, Torab SA, Pourfatollah AA. A successful experience of the Iranian blood transfusion organization in improving accessibility and affordability of plasma derived medicine. Transfus Apher Sci. 2017;56(1):12-16.
2. Cheraghali AM, Amini-Kafiabad S, Amirizadeh N, et al. Iran National Blood Transfusion Policy; Goals, Objectives and Milestones for 2011-2015. IJBC. 2011; 3(2): 35-42.
3. Cheraghali AM, Abolghasemi H. Plasma fractionation, a useful means to improve national transfusion system and blood safety: Iran experience. Haemophilia. 2009;15(2):487-93.
4. Kluszczynski T, Rohr S, Ernst R. White paper, Key Economic and Value Considerations for Plasma-Derived Medicinal Products (PDMPs) in Europe, 2020.
5. Pant S, Baga R, McGill S. International Plasma Collection Practices: Project Report. CADTH. 2021;12( 1): 1-38.
6. Plasma Shortage in Europe: Proper Investment in public blood establishments is the answer, not undermining ethical principles. EBA. Accessed August 2022. https://europeanbloodalliance.eu/plasma-shortage-in-europe-proper-investment-in-public-blood-establishments-is-the-answer-not-undermining-ethical-principles.
7. Revision of the EU legislation on blood, tissues and cells. Accessed August 2022 https://health.ec.europa.eu/blood-tissues-cells-and-organs/overview/revision-eu-legislation-blood-tissues-and-cells_en.
8. US Platelet Supply and Blood. Accessed August 2022. https://securetransfusionsolutions.com/2020/06/03/us-platelet-supply-and-demand/.
8. World Health Organization. (2021). Guidance on increasing supplies of plasma-derived medicinal products in low- and middle-income countries through fractionation of domestic plasma. World Health Organization. https://apps.who.int/iris/handle/10665/340171.
9. World Health Organization. Regional Office for the Eastern Mediterranean. (2017). Regional status report on blood safety and availability 2016. World Health Organization. Regional Office for the Eastern Mediterranean. https://apps.who.int/iris/handle/10665/258923.
2. Cheraghali AM, Amini-Kafiabad S, Amirizadeh N, et al. Iran National Blood Transfusion Policy; Goals, Objectives and Milestones for 2011-2015. IJBC. 2011; 3(2): 35-42.
3. Cheraghali AM, Abolghasemi H. Plasma fractionation, a useful means to improve national transfusion system and blood safety: Iran experience. Haemophilia. 2009;15(2):487-93.
4. Kluszczynski T, Rohr S, Ernst R. White paper, Key Economic and Value Considerations for Plasma-Derived Medicinal Products (PDMPs) in Europe, 2020.
5. Pant S, Baga R, McGill S. International Plasma Collection Practices: Project Report. CADTH. 2021;12( 1): 1-38.
6. Plasma Shortage in Europe: Proper Investment in public blood establishments is the answer, not undermining ethical principles. EBA. Accessed August 2022. https://europeanbloodalliance.eu/plasma-shortage-in-europe-proper-investment-in-public-blood-establishments-is-the-answer-not-undermining-ethical-principles.
7. Revision of the EU legislation on blood, tissues and cells. Accessed August 2022 https://health.ec.europa.eu/blood-tissues-cells-and-organs/overview/revision-eu-legislation-blood-tissues-and-cells_en.
8. US Platelet Supply and Blood. Accessed August 2022. https://securetransfusionsolutions.com/2020/06/03/us-platelet-supply-and-demand/.
8. World Health Organization. (2021). Guidance on increasing supplies of plasma-derived medicinal products in low- and middle-income countries through fractionation of domestic plasma. World Health Organization. https://apps.who.int/iris/handle/10665/340171.
9. World Health Organization. Regional Office for the Eastern Mediterranean. (2017). Regional status report on blood safety and availability 2016. World Health Organization. Regional Office for the Eastern Mediterranean. https://apps.who.int/iris/handle/10665/258923.
| Files | ||
| Issue | Vol 17, No 1 (2023) | |
| Section | Editorial | |
| DOI | https://doi.org/10.18502/ijhoscr.v17i1.11706 | |
| Keywords | ||
| Plasma; Plasmapheresis; Paid plasma; Voluntary plasma donation; World Health Organization (WHO) | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Pourfathollah AA, Shamsasenjan K, Hadipour Dehshal M. Voluntary Unpaid Plasma Donation. Int J Hematol Oncol Stem Cell Res. 2023;17(1):1-3.
